Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MHPG, amitriptyline and affective disorders. A longitudinal study

E Sacchetti, E Smeraldi, M Cagnasso

    International Pharmacopsychiatry
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A proof-of-concept study applying machine learning methods to putative risk factors for eating disorders: results from the multi-centre European project on healthy eating.

    Psychological medicine·2021
    Same author

    Visuo-tactile shape perception in women with Anorexia Nervosa and healthy women with and without body concerns.

    Neuropsychologia·2020
    Same author

    Negative symptom severity at discharge from an index hospitalization and subsequent use of psychiatric care resources: A retrospective 1-year follow-up study on 450 patients with schizophrenia spectrum disorders.

    Schizophrenia research·2019
    Same author

    Abnormal brain oscillations persist after recovery from bipolar depression.

    European psychiatry : the journal of the Association of European Psychiatrists·2017
    Same author

    Cognitive remediation and functional improvement in schizophrenia: Is it a matter of size?

    European psychiatry : the journal of the Association of European Psychiatrists·2016
    Same author

    Social cognition in people with schizophrenia: a cluster-analytic approach.

    Psychological medicine·2016
    Same journal

    A double-blind study to establish the residual effects of zopiclone on performance in healthy volunteers.

    International pharmacopsychiatry·1982
    Same journal

    Zopiclone: sleep and performance studies in healthy man.

    International pharmacopsychiatry·1982
    Same journal

    Pharmacokinetics and metabolism of zopiclone.

    International pharmacopsychiatry·1982
    Same journal

    Evaluation of zopiclone physical dependence liability in normal volunteers.

    International pharmacopsychiatry·1982
    Same journal

    Dose-finding and premedication studies with zopiclone.

    International pharmacopsychiatry·1982
    Same journal

    Efficacy and tolerance of zopiclone in insomniac geriatric patients.

    International pharmacopsychiatry·1982
    See all related articles

    This study on depression found that while amitriptyline treatment altered 3-methoxy-4-hydroxyphenylglycol (MHPG) levels, clinical improvement was independent of baseline MHPG. MHPG changes occurred faster than symptom recovery.

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Biochemistry

    Background:

    • Depression is linked to catecholamine dysfunction.
    • Urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) is a metabolite of norepinephrine, a key catecholamine.
    • Understanding MHPG's role in depression and treatment response is crucial.

    Purpose of the Study:

    • To longitudinally investigate daily urinary MHPG excretion in unipolar depressed patients.
    • To examine the effects of amitriptyline treatment on MHPG levels and depressive symptoms.
    • To explore the relationship between MHPG levels, amitriptyline response, and the time course of recovery.

    Main Methods:

    • Longitudinal study design.
    • Inclusion of five unipolar depressed patients.

    Related Experiment Videos

  • Measurement of daily urinary MHPG excretion before and during amitriptyline treatment.
  • Assessment of depressive symptom improvement.

    • Main Results:

    • Significant individual variability in pretreatment MHPG levels observed.
    • Amitriptyline modified MHPG levels, with effects potentially related to baseline MHPG.
    • Sustained improvement in depressive symptoms occurred independently of pretreatment MHPG values.
    • MHPG excretion changes occurred over a shorter time course than clinical improvement.

    Conclusions:

    • Findings support the catecholamine hypothesis of affective disorders.
    • Amitriptyline's antidepressant effects may not be solely mediated by MHPG level normalization.
    • The temporal dissociation between MHPG changes and clinical recovery warrants further investigation.